IMMUNOMOLECULAR THERAPEUTICS, INC.

Profile

Company Names

IMMUNOMOLECULAR THERAPEUTICS, INC.
IMMUNOMOLECULAR THERAPEUTICS, LLC

Addresses

299 WASHINGTON STREET, SUITE A, WOBURN, MA 01801

3513 BRIGHTON BOULEVARD, SUITE 431, DENVER, CO 80216

12635 EAST MONTVIEW BOULEVARD, AURORA, CO 80045

Phone Numbers

(303) 544-2104

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$10,849,992.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-10-30 
$7,000,000.00 
$10,000,000.00 
$3,000,000.00 
Equity 
3
2019-06-04 
$2,999,992.00 
$9,999,985.00 
$6,999,993.00 
Equity 
2
2016-07-15 
$350,000.00 
$3,000,000.00 
$2,650,000.00 
Debt 
1
2015-06-25 
$500,000.00 
$1,200,000.00 
$700,000.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JONATHAN 
 
BEHR 
DIRECTOR
IMMUNOMOLECULAR THERAPEUTICS, INC.   |  VERALOX THERAPEUTICS INC.   |  NITROME BIOSCIENCES, INC   |  QURALIS CORP   |  ENDLYZ THERAPEUTICS, INC.   |  DEMENTIA DISCOVERY FUND 2 LP   |  VIOLET THERAPEUTICS, INC.
JASON 
 
DINGES 
DIRECTOR
CANCER TARGETING SYSTEMS, INC.   |  2020, INC.   |  VIGEO THERAPEUTICS, INC.   |  PINTEON THERAPEUTICS, INC.   |  IMMUNOMOLECULAR THERAPEUTICS, INC.   |  ZIELBIO, INC.   |  APIC BIO, INC.   |  GREENLIGHT BIOSCIENCES INC.   |  INTELLIHEALTH, INC.
SEAN 
 
DOHERTY 
DIRECTOR
BROOKSIDE II CAYMAN LTD   |  BROOKSIDE CAPITAL PARTNERS FUND II, L.P.   |  SANKATY DIP OPPORTUNITIES (OFFSHORE), L.P.   |  SANKATY DIP OPPORTUNITIES, L.P.   |  BROOKSIDE CAPITAL PARTNERS FUND LP   |  BROOKSIDE CAYMAN LTD   |  BROOKSIDE CAYMAN PA LTD   |  PROSPECT HARBOR CREDIT PARTNERS OFFSHORE LP   |  PROSPECT HARBOR CREDIT PARTNERS OFFSHORE PLAN ASSETS LP   |  PROSPECT HARBOR CREDIT PARTNERS LP   |  SANKATY SENIOR LOAN FUND LP   |  SANKATY MIDDLE MARKET OPPORTUNITIES FUND, L.P.   |  SANKATY MIDDLE MARKET OPPORTUNITIES FUND (OFFSHORE), L.P.   |  SANKATY HIGH INCOME PARTNERSHIP, L.P.   |  SANKATY CREDIT OPPORTUNITIES V-A, L.P.   |  SANKATY CREDIT OPPORTUNITIES V-B, L.P.   |  SANKATY CREDIT OPPORTUNITIES V-E, L.P.   |  SANKATY CREDIT OPPORTUNITIES V-A2, L.P.   |  SANKATY CREDIT OPPORTUNITIES V-E2, L.P.   |  WURL, INC.   |  ZOOM TELEPHONICS, INC.   |  IMMUNOMOLECULAR THERAPEUTICS, INC.   |  REALIZE, INC.
PETER 
 
GOTTLIEB 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
IMMUNOMOLECULAR THERAPEUTICS, LLC   |  IMMUNOMOLECULAR THERAPEUTICS, INC.
AARON 
 
MICHELS 
PROMOTER, EXECUTIVE OFFICER
IMMUNOMOLECULAR THERAPEUTICS, LLC   |  IMMUNOMOLECULAR THERAPEUTICS, INC.
STEVE 
 
ORNDORFF 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ACCERA INC   |  MICROBIOME THERAPEUTICS, LLC   |  IMMUNOMOLECULAR THERAPEUTICS, LLC
ED 
 
ORR 
DIRECTOR, PROMOTER
IMMUNOMOLECULAR THERAPEUTICS, LLC   |  IMMUNOMOLECULAR THERAPEUTICS, INC.
NANDAN 
 
PADUKONE 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOMOLECULAR THERAPEUTICS, INC.
TOM 
 
SHEA 
EXECUTIVE OFFICER
GEAR SIX INC   |  IMMUNOMOLECULAR THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-11-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-30 
2019-06-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-04 
2016-08-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-07-15 
2015-06-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-06-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#